Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

behold.ai and Wellbeing Software collaborate on national solution for rapid COVID-19 diagnosis using AI analysis of chest X-rays

Published

on

                                                                                                    behold.ai and Wellbeing Software collaborate on
national solution for rapid COVID-19 diagnosis using AI analysis of chest X-rays
                         
Companies working to fast-track programme for UK-wide rollout
                               
LONDON, UK, March 31, 2020 – Two British companies at the leading edge of medical imaging technology are working together on a plan to fast-track the diagnosis of COVID-19 in NHS hospitals using artificial intelligence analysis of chest X-rays.behold.ai has developed the artificial intelligence-based red dot® algorithm which can identify within 30 seconds abnormalities in chest X-rays. Wellbeing Software operates Cris, the UK’s most widely used Radiology Information System (RIS), which is installed in over 700 locations.A national roll-out combining these two technologies would enable a large number of hospitals to quickly process the significant volume of X-rays, currently being used as the key diagnostic test for triage of COVID-19 patients, thereby speeding up diagnosis and easing pressure on the NHS at this critical time. This solution will also find significant utility in dealing with the backlog of cases that continue to mount, such as suspected cancer patients.Simon Rasalingham, Chairman and CEO of behold.ai, said:“behold.ai and Wellbeing are a great fit in terms of expertise and technology. We are able to prioritise abnormal chest X-rays with greater than 90% accuracy and a 30-second turnaround. If that were translated into a busy hospitals coping with COVID-19, the benefits to healthcare systems are potentially enormous.”Chris Yeowart, Director at Wellbeing Software, said:“Our technology provides the integration between the algorithm and the hospital’s radiology systems and working processes, addressing the technical challenges to clearing the way for accelerated national rollout. It is clear from talking to radiology departments that chest X-rays have become one of the primary diagnostic tools for COVID-19 in this country.”https://www.behold.aihttps://www.wellbeingsoftware.com/Ends
For further information, please contact:
Consilium Strategic Communications
Tel: +44(0)20 3709 5700
[email protected]
About behold.ai and radiologybehold.ai provides artificial intelligence, through its red dot® cognitive computing platform, to radiology departments. This technology augments the expertise of radiologists to enable them to report with greater clinical accuracy, faster and more safely than they could before. This revolutionary combination helps to deliver greater performance in radiology reporting at a fraction of the price of outsourced reporting.Radiology departments play an essential role in the diagnostic process; however, a consequence of fewer radiologists and a growing demand for images has left services stretched beyond capacity across many trusts, resulting in reporting delays – in some cases impacting cancer diagnosis. These service issues have been highlighted by the Care Quality Commission and the Royal College of Radiologists.Our solution seamlessly integrates into local trust workflows augmenting clinical practice and delivering state-of-the-art, safe, Artificial Intelligence.  The behold.ai algorithm has been developed using more than 30,000 example images, all of which have been reviewed and reported by highly experienced consultant radiology clinicians in order to shape accurate decision making. The red dot® prioritisation platform is capable of sorting images into normal and abnormal categories in less than 30 seconds post image acquisition.About behold.ai and qualityApart from its FDA clearance, behold.ai is also CE approved and is gaining further approval for a CE mark Class IIa certification.In June 2019 the Company was awarded ISO 13485 QMS certification for an AI medical device – the ‘gold standard’ of quality certification.About Wellbeing SoftwareWellbeing Software is a leading healthcare technology provider with a presence in more than 75% of NHS organisations. The company has combined its extensive UK resources and unparalleled experience in its specialist divisions – radiology, maternity, data management and electronic health records – to form Wellbeing Software, uniting their core businesses to enable customers to build on existing investments in IT as a way of delivering connected healthcare records and better patient care. 
Wellbeing’s ability to connect its specialist systems with other third-party software enables healthcare organisations to achieve key objectives, such as paperless working and the creation of complete electronic health records. Through their established footprint, specialist knowledge and significant development resources, the company is building the foundations for connectivity within NHS organisations and beyond.
Wellbeing media contact : Jenni Livesley, Context Public Relations, [email protected]

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

ShapeBlue, the CloudStack company, announces a partnership with proIO to deliver private cloud services in Germany, aimed at meeting growing demand in the region

Published

on

shapeblue,-the-cloudstack-company,-announces-a-partnership-with-proio-to-deliver-private-cloud-services-in-germany,-aimed-at-meeting-growing-demand-in-the-region

FRANKFURT, Germany, April 30, 2024 /PRNewswire/ — ShapeBlue, a leader in delivering CloudStack engineering services and support, announces a partnership with proIO, a German Private Cloud Provider empowering SMBs across various industries through its Infrastructure-as-a-Service and Managed Hosting solutions. This collaboration marks a milestone in advancing cloud infrastructure and support for organizations in the region, implementing Apache CloudStack as their IaaS platform.

Both companies recognize the benefits of having control over your cloud infrastructure and having a reliable partner delivering a fully managed IaaS solution. Embracing a managed private cloud environment ensures better cost management and enhances security measures, maximizes hardware investments, ensures flexibility and compliance with regulations. Utilizing CloudStack to orchestrate the IT environment offers companies unparalleled flexibility to tailor their infrastructure to their unique needs while leveraging existing resources effectively.
Giles Sirett, CEO of ShapeBlue commented: “With the partnership with proIO we address the needs of SMBs in Germany for powerful managed cloud. We will focus on adoption of open-source technology, helping them to control costs and ensure reliability.
ShapeBlue has a global footprint, with customers in 19 countries. Driven by the desire of organisations to repatriate cloud workloads and changes in the market, with proIO we aim to repeat the success that we have in other markets.”
proIO and ShapeBlue join forces to help companies in Germany harness the potential of open-source technology backed up by reliable support.
“With our expertise and proven offerings, we will develop innovative solutions and deliver optimal results. We are convinced that this partnership will open up further opportunities and that we can achieve even more together. We look forward to working with ShapeBlue to develop forward-thinking solutions and support our customers in the best possible way.”, says Swen Brüseke, CEO at proIO.
This new partnership allows German companies to benefit from the local presence of proIO, their experience as a CloudStack integrator and ShapeBlue’s 100s of man-years of experience in designing and building complex cloud, network, and storage infrastructure with Apache CloudStack.
proIO
proIO is a Private Cloud Provider empowering German SMBs through its Infrastructure-as-a-Service and Managed Hosting solutions, based in Frankfurt, Germany.
ShapeBlue
ShapeBlue is the largest independent integrator of CloudStack technologies globally and specialists in designing and implementing IaaS cloud infrastructures for private and public cloud implementations.

View original content:https://www.prnewswire.co.uk/news-releases/shapeblue-the-cloudstack-company-announces-a-partnership-with-proio-to-deliver-private-cloud-services-in-germany-aimed-at-meeting-growing-demand-in-the-region-302128774.html

Continue Reading

Artificial Intelligence

Implantica Announces Real-World Clinical Data from over 200 Patients treated across five RefluxStop™ Centers in Europe Presented at SAGES in Cleveland

Published

on

implantica-announces-real-world-clinical-data-from-over-200-patients-treated-across-five-refluxstop™-centers-in-europe-presented-at-sages-in-cleveland

VADUZ, Liechtenstein, April 30, 2024 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, reports many presentations including new RefluxStop™ real-world data from over 200 patients at five hospitals across Europe, were presented in Scientific Sessions at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Scientific Meeting.

This highly esteemed conference is the biggest meeting in the world dedicated specifically to gastrointestinal and endoscopic surgery. Some 2,500 SAGES members, representing the world-leading experts in gastrointestinal and endoscopic surgery, attended the SAGES Annual Meeting in Cleveland, Ohio on April 17-20.
It’s a credit to the ongoing enthusiasm for RefluxStop™ to see the latest clinical data from five world-renowned European centers of excellence in the treatment of acid reflux diseases, presented at SAGES. The Centers of Excellence included the following:
Krankenhaus Nordwest GmbH, Frankfurt, Germany Presenting author: Dr. Moustafa ElshafeiHirslanden Beau-Site Hospital, Bern, Switzerland Presenting author: Dr. Joerg ZehetnerInselspital, University Hospital, Bern, Switzerland Presenting author: Dr. Yves BorbélyAKH University Hospital Vienna, AustriaPresenting author: Prof. Dr. Sebastian SchoppmannClinics for General and Visceral Surgery, Klinikum Friedrichshafen, GermanyPresenting author: Dr. Thortsen G. LehmannDr. Peter Forsell, CEO of Implantica says, “The excellent real-world outcomes from a dataset that is four times bigger than the size of the CE study conducted more than five years ago is a strong validation of the consistent and sustained outcomes of the RefluxStop therapy. This research further establishes RefluxStop™ as an exceptional surgical treatment for GERD, setting the stage for strong future growth in US once we get market approval.”
Dr. Forsell goes on to say, “There has been an immense interest and support in RefluxStop™ therapy from the US surgeons and scientific experts. Looking to the US market where 20% of the adult population suffers from GERD1, we see a massive opportunity for the innovative RefluxStop™ procedure to transform patients’ quality of life, pending FDA approval.”
Fass R, Frazier R. The role of dexlansoprazole modified-release in the management of gastroesophageal reflux disease. Therap Adv Gastroenterol. 2017 Feb;10(2):243-251. doi: 10.1177/1756283X16681701. Epub 2017 Jan 5. PMID: 28203282; PMCID: PMC5298478.For further information, please contact:Nicole Pehrsson, Chief Corporate Affairs OfficerTelephone (CH): +41 (0)79 335 09 [email protected]
Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.
The company’s Certified Adviser is FNCA Sweden AB, [email protected]
The information was sent for publication, through the agency of the contact person set out above, on April 30, 2024, at 08:00 a.m. (CET).
About Implantica
Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica’s lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energizing platform designed to power remote-controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.
About RefluxStop™
RefluxStop™ is a new innovative treatment that has the potential to spur a paradigm shift in anti-reflux surgery. It’s unique mechanism of action differentiates it from standard of care and current surgical solutions. Longer established surgical options for GERD involve encircling the food passageway to support the lower esophageal sphincter’s closing mechanism and are commonly associated with side effects such as swallowing difficulties, pain when swallowing and inability to belch and/or vomit.
In contrast, the RefluxStop device treats the cause of acid reflux without encircling and putting pressure on the food passageway. It restores and maintains the lower esophageal sphincter in its original, natural position.
The RefluxStop™ mechanism of action is focused on reconstructing all three components of the anti-reflux barrier, that if compromised could possibly result in acid reflux. It restores and supports the natural anatomical physiology of the body allowing the body to itself solve the problem with acid reflux.
Newsroomhttps://www.implantica.com/media/media-kit
Communityhttps://ch.linkedin.com/company/implanticahttps://www.twitter.com/implantica
Media Contact:Juanita Eberhart, VP Marketing & AdvocacyM: +1 [email protected]
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/implantica/r/implantica-announces-real-world-clinical-data-from-over-200-patients-treated-across-five-refluxstop-,c3970435
The following files are available for download:
https://mb.cision.com/Main/19732/3970435/2769366.pdf
Implantica Announces Real-World Clinical Data from over 200 Patients treated across five RefluxStop™ Centers in Europe Presented at SAGES in Cleveland
 

View original content:https://www.prnewswire.co.uk/news-releases/implantica-announces-real-world-clinical-data-from-over-200-patients-treated-across-five-refluxstop-centers-in-europe-presented-at-sages-in-cleveland-302131141.html

Continue Reading

Artificial Intelligence

Inspira Enterprise Named a Leader in the 2024 IDC MarketScape Report for Worldwide Emerging MDR Services

Published

on

inspira-enterprise-named-a-leader-in-the-2024-idc-marketscape-report-for-worldwide-emerging-mdr-services

DALLAS, April 30, 2024 /PRNewswire/ — Inspira Enterprise, Inc. (‘Inspira’), a global cybersecurity services organization is proud to announce that it has been positioned in the Leaders category in the 2024 IDC MarketScape Report for worldwide emerging managed detection and response (MDR) services.

In the assessment conducted by IDC for its MarketScape, vendors were meticulously scrutinized against a comprehensive array of benchmarks encompassing, functionality, offerings, security outcomes, go-to-market strategy, customer portal, talent management, service tiers, range of services, future outlook, security outcome, and cost normalization. IDC’s discerning evaluation heralded Inspira’s proactive detection and closed-loop remediation, as the integral components of its cutting-edge Intelligence-Driven Cyber Defense (ICD) practice.  
According to the IDC MarketScape Report, “MDR services have experienced significant growth, fueled by the escalating sophistication and frequency of cyber threats. Organizations are increasingly turning to MDR services as the cornerstone of fortifying their digital fortresses against the relentless tide of evolving cyber threats. to enhance their overall cybersecurity posture. This strategic shift underscores a profound recognition of the imperative to not merely respond reactively but to proactively anticipate and neutralize emerging risks with unparalleled agility and efficacy.” 
Commenting on Inspira’s strengths, Yogesh Shivhare, Research Manager, Security & Infrastructure, at IDC Canada stated, “Inspira Enterprise’s MDR offering extends beyond threat containment to include a closed-loop remediation process. After containment, this process ensures that enterprise-wide policies and configurations are updated, effectively preventing future attacks using similar methods. This process enables Inspira’s service to improve analyst interaction and develop a deeper understanding of the client’s context.” He also added, “Inspira Enterprise brings a wealth of experience in providing threat detection and response services in complex environments, particularly for midmarket and enterprise clients in the banking and financial services (BFSI), healthcare and life sciences (HCLS), and public sector, with steady adoption of its services within organizations in other industry verticals.”
Inspira’s visionary approach is epitomized by its formidable arsenal of accelerators which forms the foundation for assisting its clientele to transition from their incumbent security information and event management solutions to Inspira’s state-of-the-art MDR platform. Automation and orchestration are foundational to Inspira’s MDR service, with over 130+ playbooks facilitating a 15-minute detection, 30-minute containment, and 4-hour remediation SLA for highest severity incidents.
“Our team is indeed honored to be recognized by IDC MarketScape as a Leader for Worldwide MDR Services,” said Chetan Jain, Managing Director, of Inspira Enterprise. “This acknowledgment is a validation of our commitment to safeguard our clients’ digital assets. We tailor our MDR services to the business context, by integrating SIEM, UEBA, SOAR, and TIP capabilities while also delivering a unified cyber-risk dashboard to provide visibility into threat detection coverage and maturity. We cater to midsize to large clients with complex IT environments who are looking to completely outsource cyber defense or augment their existing SOC efforts.”
Inspira Enterprise has invested significantly in developing its native MDR platform, (iMDR), expected to be available to clients in 2024. This platform will bring advanced detection and hunting capabilities along with a GenAI-enabled dashboard embedded in its iSMART2 customer portal. Inspira Enterprise is also diversifying its services with offerings like deception as a service, IT-OT converged SOC, and continues to invest in service offerings and automation to improve SOC Program Governance through measurable and actionable KPIs. Inspira Enterprise’s proactive stance and ongoing investments position it as a forward-thinking partner in the dynamic field of managed detection and response services.
Read more: https://inspiraenterprise.com/ugiltecm/2024/04/IDC-MarketScape-Worldwide-Emerging-Managed-Detection-and-Response-Services-2024-Vendor-Assessment-2024-Apr.pdf
About Inspira
Inspira Enterprise is a global Cybersecurity, Data Analytics, and AI services provider with a presence in North America, ASEAN, the Middle East, India, and Africa regions. It offers a wide range of services for Banking, Financial Services and Insurance (BFSI), Healthcare, Public Sector, Manufacturing, Information Technology Enabled Services (ITeS), eCommerce, and others. Inspira’s cybersecurity services range from basic perimeter security to complex incident management and response and managed security services. The organization’s global partnerships with best-of-breed technology providers enable it to offer cutting-edge cybersecurity solutions. Inspira’s Managed Analytics service supports its customer’s IT and Business teams, to bridge data strategies with business outcomes. 
About IDC MarketScape:
IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.
Media Contact:
[email protected]+91 2240569999
Logo: https://mma.prnewswire.com/media/2400111/Inspira_Enterprise_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/inspira-enterprise-named-a-leader-in-the-2024-idc-marketscape-report-for-worldwide-emerging-mdr-services-302130176.html

Continue Reading

Trending